Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Wilms' Tumor (WT1) Antigen-targeted Dendritic Cell Vaccination to Prevent Relapse in Adult Patients With Acute Myeloid Leukemia: a Multicenter Randomized Phase II Trial

NCT01686334 is registered in ClinicalTrials.gov with Zwi Berneman as lead sponsor.

NCT NCT01686334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01686334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Wilms' Tumor (WT1) Antigen-targeted Dendritic Cell Vaccination to Prevent Relapse in Adult Patients With Acute Myeloid Leukemia: a Multicenter Randomized Phase II Trial
Lead sponsor
Zwi Berneman
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 31, 2012
Completion date
December 31, 2027
Enrollment
130 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia